Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Velka Gverić-Krečak

797

Velka

Gverić-Krečak

mr. sc.

nije evidentirano
Naziv Akcije
Krečak, Ivan ; Holik, Hrvoje ; Morić Perić, Martina ; Zekanović, Ivan ; Coha, Božena ; Gverić-Krečak, Velka ; Lucijanić, Marko Serum osmolarity in polycythemia vera and its clinical associations // International journal of laboratory hematology, Online ahead of (2022), 1-4. doi: 10.1111/ijlh.13844
Krečak, Ivan ; Holik, Hrvoje ; Morić Perić, Martina ; Zekanović, Ivan ; Coha, Božena ; Gverić-Krečak, Velka ; Marko, Lucijanić High platelet-to-lymphocyte ratio may differentiate polycythemia vera from secondary polycythemia // Wiener klinische Wochenschrift, 134 (2022), 11-12; 483-486. doi: 10.1007/s00508-022-02027-w
Krečak, Ivan ; Holik, Hrvoje ; Zekanović, Ivan ; Morić Perić, Martina ; Marketin, Tina ; Coha, Božena ; Gverić-Krečak, Velka ; Vodanović, Marijo ; Lucijanić, Marko Thrombotic risk in secondary polycythemia resembles low-risk polycythemia vera and increases in specific subsets of patients // Thrombosis research, 209 (2022), 47-50. doi: 10.1016/j.thromres.2021.11.025
Krečak, Ivan ; Ruščić, Ivana ; Zlatović, Josipa Jović ; Šupe, Marijana ; Krečak, Marija Valovičić ; Gverić-Krečak, Velka Paraneoplastic aortitis in a patient with relapsed multiple myeloma successfully treated with daratumumab, bortezomib and dexamethasone // Annals of hematology, 100 (2021), 6; 1623-1624. doi: 10.1007/s00277-020-04369-9
Krečak, Ivan ; Čengić, Marina ; Skorić, Ivana ; Nakić, Mirjana ; Gverić-Krečak, Velka Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib // Annals of hematology, 100 (2021), 11; 2861-2862. doi: 10.1007/s00277-021-04570-4
Krečak, Ivan ; Holik, Hrvoje ; Zekanović, Ivan ; Morić-Perić, Martina ; Coha, Božena ; Gverić- Krečak, Velka Autoimmune disorders and the risk of thrombotic events in polycythaemia vera // Leukemia research, 110 (2021), 34274855, 3. doi: 10.1016/j.leukres.2021.106667
Krečak, Ivan ; Peran, Nena ; Lapić, Ivana ; Gverić- Krečak, Velka ; Krečak, Filip ; Rončević, Pavle ; Duraković, Nadira Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms // Wiener klinische Wochenschrift, 133 (2021), 62-64. doi: 10.1007/s00508-020-01651-8
Krečak, Ivan ; Holik, Hrvoje ; Coha, Božena ; Perić, Martina Morić ; Zekanović, Ivan ; Krečak, Marija Valovičić ; Gverić-Krečak, Velka ; Lucijanić, Marko Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera // Annals of hematology, 100 (2021), 5; 1335-1336. doi: 10.1007/s00277-021-04431-0
Krečak, Ivan ; Morić Perić, Martina ; Zekanović, Ivan ; Holik, Hrvoje ; Coha, Božena ; Gverić-Krečak, Velka ; Lucijanić, Marko No impact of the increased number of cardiovascular risk factors on thrombosis and survival in polycythemia vera // Oncology research and treatment, 44 (2021), 4; 201-203. doi: 10.1159/000514347
Krečak, Ivan ; Morić Perić, Martina ; Zekanović, Ivan ; Holik, Hrvoje ; Coha, Božena ; Gverić-Krečak, Velka ; Lucijanić, Marko Beneficial effect of ACE inhibitors on kidney function in polycythemia vera // Wiener klinische Wochenschrift, 133 (2021), 15-16; 808-815. doi: 10.1007/s00508-021-01812-3
nije evidentirano
nije evidentirano